Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sowalsky
    Junior Member
    • Oct 2012
    • 4

    BCFTools missing mutation at 8%

    I am having difficulty figuring out why bcftools is not calling my SNP. When I run samtools mpileup, the position is being "piled up" properly but it is not being interpreted as a SNP. It is a position read at extremely high depth (100,000x).

    Here is how I am invoking the pileup/mutation calling:

    samtools mpileup -d10000000 -BRuf ~/hg19.fa alignment.bam | bcftools view -vcg ->snps.vcf
    I have tried varying the -t and -p options in bcftools view without success.

    If I omit -v from bcftools, I see that bcftools is not regarding the position as a variant. Here is the output from that line:

    chrX 66941716 . G . 283 . DP=113309;AF1=0;AC1=0;DP4=54138,47121,4400,3713;MQ=25;FQ=-282;PV4=0.18,1,1,1 PL 0
    So as you should see there are significant reads at the position that should support the SNP. Does anyone have any suggestions?
  • sowalsky
    Junior Member
    • Oct 2012
    • 4

    #2
    Just a follow-up. By using:

    samtools mpileup -d10000000 -BRuf ~/hg19.fa alignment.bam | bcftools view -p 2 -vcg ->snps.vcf
    it forced bcftools to consider my mutation but it gave it a really poor quality score. It found:

    chrX 66941716 . G A -0 . DP=113309;AF1=0;AC1=0;DP4=54138,47121,4400,3713;MQ=25;FQ=-282;PV4=0.18,1,1,1 GT:PL:GQ 0/0:0,255,255:99
    The original bam file was from RNA-seq of a highly-heterogeneous population. Is there a way to control for this, so bcftools would accept this as a genuine mutation and not score it so poorly?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 12:17 PM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...